Greiner Bio-One - Invests EUR 500 million in USA
As of now, Greiner Bio-One is investing in the expansion of production facilities in the USA (Monroe, North Carolina). Construction of the additional hall will cost around EUR 5 million. This will make space for an additional VACUETTE® plant, which will increase the factory's capacity by 60 million VACUETTE® tubes.
In the course of the expansion 30 new jobs will be created. 840 million tubes will be produced this year in Kremsmünster and Monroe. This makes Greiner Bio-One one of the biggest manufacturers of plastic blood collection tubes in the world. During the last financial year the VACUETTE® market share was further increased. In Austria the current market share is approx. 80%.
Other news from the department manufacturing
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.